United States S 474: Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019

Status: Introduced in Senate (as of 2019-02-13)

State: United States · Session: 116 · Bill: S 474

Subjects: Civil actions and liability, Corporate finance and management, Government information and archives, Inflation and prices, Marketing and advertising, Prescription drugs, Research and development

Sponsors: RON WYDEN, Amy Klobuchar, BENJAMIN L. CARDIN, Catherine Cortez Masto, Christopher A. Coons, DEBORAH ANN STABENOW, Gary C. Peters, Jon Tester, Kirsten E. Gillibrand, Robert Menendez, THOMAS R. CARPER, Tammy Duckworth, Tina Smith

View United States S 474 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.